HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

BKI-1553

an inhibitor of calcium-dependent protein kinase 1; structure in first source

Networked: 2 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Heterocyclic Compounds: 198
- 1-Ring Heterocyclic Compounds
  - Azoles: 2138
    - Pyrazoles: 61
      - BKI-1553: 2
  - Pyrimidines: 510
    - BKI-1553: 2

Experts

1.	Barrett, Lynn K: 2 articles (01/2018 - 12/2016)
2.	Choi, Ryan: 2 articles (01/2018 - 12/2016)
3.	Hulverson, Matthew A: 2 articles (01/2018 - 12/2016)
4.	Ojo, Kayode K: 2 articles (01/2018 - 12/2016)
5.	Rivas, Kasey L: 2 articles (01/2018 - 12/2016)
6.	Van Voorhis, Wesley C: 2 articles (01/2018 - 12/2016)
7.	Benavides, Julio: 1 article (01/2018)
8.	Blanco-Murcia, Javier: 1 article (01/2018)
9.	Castaño, Pablo: 1 article (01/2018)
10.	Ferre, Ignacio: 1 article (01/2018)

Related Diseases

1.	Infections 12/01/2016 - "The experimental infected groups treated for 30days with compound BKI-1553 (n=10 mice) had no signs of disease, while the infected control group had severe signs and symptoms of infection. " 01/01/2018 - "BKI-1553 treatment decreased fever in infected pregnant ewes already after two applications, resulted in a 37-50% reduction in foetal mortality, and modulated immune responses; IFNγ levels were increased early after infection and IgG levels were reduced subsequently. "
2.	Fever (Fevers) 01/01/2018 - "BKI-1553 treatment decreased fever in infected pregnant ewes already after two applications, resulted in a 37-50% reduction in foetal mortality, and modulated immune responses; IFNγ levels were increased early after infection and IgG levels were reduced subsequently. "

Related Drugs and Biologics

1.	Immunoglobulin G (IgG)